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In the analysis of gene expression proﬁles, the selection of genetic markers and precise diagnosis of can-
cer type are crucial for successful treatment. The selection of discriminatory genes is critical to improve
the accuracy and decrease computational complexity and cost in microarray analysis. In this paper, we
developed a new statistical parameter, the suitability score to ﬁlter genes which only utilize sample dis-
tances from the class centroid. The ﬁltered genes are employed in the nearest centroid classiﬁcation to
classify cancer. To evaluate the performance of the new statistical parameter, the proposed approach
is applied to three publicly available microarray datasets. In this paper we demonstrate that the proposed
gene selection method is steady in handling classiﬁcation tasks and is a useful tool for gene selection and
mining high dimension data.
 2008 Elsevier Inc. All rights reserved.1. Introduction
Microarray technology is the central platform for functional
genomics and translational research by monitoring activities of
thousands of genes simultaneously. Microarray analysis has yet
to be widely accepted for extracting disease-relevant genes, diag-
nosis, and classiﬁcation of human tumor [1–3]. The selection of ge-
netic markers and precise diagnosis of cancer type are crucial for
successful treatment. In the analysis of gene expression proﬁles,
the number of tissue samples with genes expression levels avail-
able is usually smaller compared with the number of genes and
most of the monitored expression gene may not be relevant to
pathological state. These genes may potentially degrade the classi-
ﬁcation performance of data analysis by masking the contribution
of the relevant genes and it can lead either to possible overﬁtting
and dimensional curse or even to a complete failure in analysis
of microarray data [4–8]. An efﬁcient way to solve this problem
is gene selection and the selection of discriminatory genes is criti-
cal to improving the accuracy and decreasing computational com-
plexity and cost.
To circumvent this problem, two basic approaches for gene
selection appear in machine learning and pattern recognition liter-
ature: the ﬁlter and wrapper techniques. Filter procedures are used
in most of the works in the area of DNAmicroarray which based on
gene ranking. In these gene ranking approaches, genes are ranked
according to their score and the genes with highest scores are se-
lected. These methods include t-test, Relief-F, information gain,
Kruskal–Wallis rank and so on. These gene ranking methods are
easy to understand and implement. But these methods select genesll rights reserved.based on individual contribution without according for mutual
information among genes. The selection process is independent
of the classiﬁer so that the result is usually not satisﬁed. Some of
these methods such as t-test and Wilcoxon rand sum test have a
potential limitation to extent in the case of more than two classes
and require time consuming adjustment to solve the problem of
multiple testing [2,9]. Kruskal–Wallis test can be used for multi-
class, but it may produce biased results in applying to data whose
sample sizes are usually unbalanced [10]. The nearest shrunken
centroid method suggested by Tibshirani et al. [11,12] was demon-
strated to be able to identify discriminant genes for multiple can-
cer types by a shrinkage parameter. Few variable selection
methods took up with hunting for class-speciﬁc genes for each
cancer type and the genes containing important information about
the subtypes of cancers are eliminated by them. Dabney [13] pro-
posed classiﬁcation to nearest centroids (ClaNC) method which
carries out class-speciﬁc feature selection and ClaNC error rates
are small. ClaNC does not shrink centroids and allows each gene
to be active in at most one class.
Various clustering, classiﬁcation, and prediction techniques
have been used to analyze and understand the gene expression
data resulted from DNA microarray, such as Fisher discriminant
analysis and support vector machine (SVM). Most of the proposed
methods cannot be directly applied to multiclass model and need
to combination several binary classiﬁers to develop multiclass
classiﬁcation procedure.
In this paper, we develop a new statistical parameter, the suit-
ability score to ﬁlter gene and classify cancer. Similar to ClaNC, the
suitability score method ranked and selected gene for each cancer
type and than employed the nearest centroid classiﬁcation to clas-
sify cancer. However, unlike ClaNC, the suitability score only utilize
sample distances from the class centroid. Compared to ClaNC and
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implement, there are few parameters to adjust. The proposed
methods can be extended to the case of more than two classes.
Gene selection by suitability score and the nearest centroid classi-
ﬁer are all based on class centroid, the principle of them are iden-
tical, so the classiﬁcation result is satisﬁed. To evaluate the
performance of the new statistical parameter, the proposed ap-
proach is applied to three publicly available microarray datasets.
In this paper we demonstrate that the proposed gene selection
method is a useful tool for gene selection and mining high dimen-
sion data.
2. Methods
The gene selection is an important aspect for class identiﬁcation
and it is important to decide whether a gene is differentially ex-
pressed among different classes. If a gene is suitable for classiﬁca-
tion, the expression of this genes for the samples belonging to the
same class are close and the expression of this genes for the sam-
ples belonging to the different class may differ greatly. The basic
idea of this method is to determine which genes vary most signif-
icantly among classes and to select genes for each cancer type.
Using the new statistical parameter, the criterion of selection gene
for class k is to identify genes which have short distances from cen-
troid of class k and have large distances from other class centroid.
Gene expression data with p probes and n DNA samples can be
described by a p  n data matrix, X and xij be the expression for the
ith gene and jth sample. Gene expression levels for each gene were
preprocessed by subtracting the lowest value and dividing by the
range of that gene. The expression levels for each gene are scaled
on [0,1]. Suppose that the data have total K classes. Deﬁne Ck to
be the index of the samples in the class k and let nk be the number
of samples in the kth category.
The ith element of the overall centroid is deﬁned as:
xi ¼ 1=n
Xn
j¼1
xij ð1Þ
The ith element of the centroid for class k is represents the
mean expression value in class k for gene i. It is deﬁned as follows:
xik ¼ 1=nk
X
j2Ck
xij ð2Þ
For class k, a satisﬁed gene is that the samples of class k are clo-
sely located around the centroid of class k, have short distances
from the centroid of class k and have large distances from other
class centroid. To select satisﬁed genes, we ﬁrst calculate a distance
ratio Di to represent the distributing status of the expression of
gene i. dik is the element of Di:
dik ¼
P
l not equal to k
P
j2Cl
ðxij  xilÞ2
" #,
ðK  1Þ
P
j2Ck
ðxij  xikÞ2
ð3Þ
where the denominator of dik is the sum of within-class squared
distance for class k and the numerator of dik is the sum of average
squared distance from the centroid of classes except k. The numer-
ical value of this distance ratio dik arising from two different distri-
butions gives us a measure of the disparity of the among-class
distance and within-class distance.
Moreover, a favorable gene for class k is differentially expressed
between centroid of class k and the overall centroid. Thus, we de-
velop a new statistical parameter which reﬂects the suitability of
gene i for class k as follows:
sik ¼ ðxik  xiÞ  dik ð4ÞThe large absolute value of sik suggests that samples of the ith
gene in class k are far from the centroid of other classes and are
assembled around the centroid of class k, so large absolute sik value
indicates interesting gene and the gene i is suitable for distinguish-
ing class k from others.
After the suitability of genes is calculated, genes are ranked
according to their absolute scores for each class and the genes with
highest scores are selected. The gene selection also involves the
detection and removal of those genes which exhibit high pair-wise
correlations with other genes. Pairs of genes that are highly corre-
lated (rP 0.80) encoded similar information, only the larger in
score is chosen and the other one should be removed. Using a cor-
relation based approach, the redundancy of the ﬁltered genes is re-
moved and a candidate subset is generated for each class.
We selected genes in the light of the distance from centroid and
the nearest centroid classiﬁer is also based on class centroid, so the
nearest centroid classiﬁcation was employed for classiﬁcation of
samples. The nearest centroid method is a fast and simple algo-
rithm for classiﬁcation. Nearest centroid classiﬁcation takes the
gene expression proﬁle of a new sample, and compares it to each
of these class centroids then assigns a test sample to the class with
the closest centroid.
The gene selection and nearest centroid classiﬁcation algorithm
were written in Matlab 5.3 and run on a personal computer.3. Results and discussion
In the present study, three publicly available datasets are used
to test the performance of our method in gene selection for tumor
classiﬁcation. The performance of gene subset is measured accord-
ing to an averaged classiﬁcation error rates over ﬁvefold cross-val-
idation. Classiﬁcation error rate is the percentage of the number of
misclassiﬁcations to the total number of samples. To avoid gene
selection bias, genes selection is done with the cross-validation
loop using the training set only and not uses the same selected fea-
ture for all iterations [14]. Because of the arbitrariness of partition
of dataset, the predicted error rate of a model at each iteration is
not necessarily the same. To evaluate accurately the relevance of
genes subset, such ﬁvefold cross-validation was repeated 200
times and then averaged the error rate.
3.1. Small round blue cell tumors
The ﬁrst dataset involves small round blue cell tumors (SRBCT)
of childhood [15]. It is comprised expression measurements on
2308 genes in 83 SRBCT samples (excluding the ﬁve non-SRBCT
samples). The tumors are classiﬁed as Burkitt lymphoma (BL), Ew-
ing sarcoma (EWS), neuroblastoma (NB), or rhabdomyosarcoma
(RMS). Following the experimental setup of the original authors,
the data is split into a training set consisting of 63 samples, and
a test set of 20 samples.
We ﬁrstly compute the suitability score of each gene for each
class and then rank all genes according to the suitability score from
the minimum to the maximum. Fig. 1 shows the suitability score of
each gene in the SRBCT data. For each class k, the informative genes
which have largest suitability score are that suitable for distin-
guishing class k from others. As shown in Fig. 1, there are only a
small number of genes which are informative for each tumor type.
For SRBCT dataset, we selected 1–10 and 15 top-ranked genes for
each class for classiﬁcation, respectively (see Supplementary mate-
rial). Table 1 summarizes the result of averaged classiﬁcation error
rates over ﬁvefold cross-validation. The suitability score requires
16 genes to drop the error bellow 10% and needs 24 genes for bel-
low 5%. Using 32 active genes, the error rate is 2.0%. The 32 gene
model provides the sensitivity 95.94% and speciﬁcity 99.12% for
Fig. 1. The suitability score of each gene in the SRBCT data.
Table 1
Averaged classiﬁcation error rates over ﬁvefold cross-validation of our proposed suitability score method and previously published one [15]
Dataset Method Number of gene selected for each class
1 2 3 4 5 6 8 9 10 15
SRBCT Suitability 0.23 0.17 0.11 0.08 0.06 0.05 0.02 0.016 0.016 0.013
PAM 0.46 0.43 0.27 — 0.06 — — — 0.05 0.07
ClaNC 0.13 0.07 0.04 — 0.05 — — — 0.06 0.04
Leukemia Suitability 0.15 0.12 0.08 0.09 0.09 0.09 0.06 0.05 0.04 0
PAM 0.47 0.32 0.18 — 0.11 — — — 0.05 0.05
ClaNC 0.18 0.11 0.11 — 0.05 — — — 0.05 0.03
Lymphoma Suitability 0.13 0.05 0.03 0.02 0.01 0.005 0.003 0.001 0.001 0.003
PAM 0.28 0.34 0.33 — 0.24 — — — 0.14 0.33
ClaNC 0.10 0.09 0.03 — 0.02 — — — 0.03 0.02
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outcome with a sensitivity and speciﬁcity of 99.85% and 98.89%
for Ewing sarcoma (EWS). For neuroblastoma (NB), the 32 genes
classify emerged with a sensitivity and speciﬁcity of 98.10% and
98.51%, respectively, whereas for rhabdomyosarcoma (RMS), we
found it with a Sensitivity and speciﬁcity of 99.12% and 99.97%.
Dabney [13] developed a new technique (ClaNC) for gene selection
and compared with prediction analysis of microarrays (PAM) for
SRBCT data. PAM error rates are <10% with 20 genes and needs
40 genes for 5%. ClaNC requires only 8 genes for 10% error rate,
whereas needs 40 genes for 6%. As a comparison, the minimum er-
ror rate can be obtained in the classiﬁcation process by the suit-
ability score and the misclassiﬁcation error rate for suitability
score (2%) is lower than that for ClaNC (6%) and PAM (5%).
The real goal in developing new technique for gene selection is
to classify a new sample. To check the validity of the proposed suit-
ability score methods, 63 samples were used as the training set for
selecting genes and developing classiﬁcation models, while the
remaining 20 samples were used as the test set. We selected 1–
40 top-ranked genes for each class for classiﬁcation, respectively.
The error rate of training and test set is shown in Fig. 2. As shown
in Fig. 2, the training and test error rate tends to decrease with
including information genes. The error rate for training set reached
to zero using 10 genes for each class. The test set showed theminimum error (0) when 26–34 genes for each class used, indict-
ing our method is steady in handling classiﬁcation tasks. The test
error rates reached to zero using 43 active genes by PAM and a
set of 32 genes obtained 100% accuracy by ClaNC.
3.2. Leukemia dataset
The second dataset on acute leukemia classiﬁcation was origi-
nally analyzed by Golub et al. [16]. The dataset contains gene
expression levels for 7129 genes from two classes of leukemia:
acute lymphoblastic leukemia (ALL) and acute myeloblastic leuke-
mia (AML). A total of 38 training samples (27 ALL and 11 AML) and
34 test samples (20 ALL and 14 AML) were provided.
Fig. 3 shows the suitability score of each gene in the leukemia
dataset. Similar to SRBCT data, only a small number of genes are
suitable for distinguishing the two classes. We also selected 1–10
and 15 top-ranked genes for the two classes for classiﬁcation,
respectively (see Supplementary material). Table 1 summarizes
the result of averaged classiﬁcation error rates over ﬁvefold
cross-validation. The suitability score requires 18 genes to drop
the error rate bellow 5%. The 18 gene model provides the sensitiv-
ity 81% and speciﬁcity 98.7%. Using 30 active genes, the error rate
reach to zero and the sensitivity and speciﬁcity are all equal 1. PAM
needs 20 genes for 5% error and ClaNC requires only 10 genes.
Fig. 3. The suitability score of each gene in the Leukemia data.
Fig. 2. Classiﬁcation error rate of SRBCT data.
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ClaNC methods, respectively. The zero error rate can be obtained in
the classiﬁcation process by the suitability score and the misclassi-
ﬁcation error rate for suitability score is lower than that for ClaNC
(3%) and PAM (5%).
To predict a new sample, 38 samples were used as the
training set for selecting genes and developing classiﬁcation
models, while the remaining 34 samples were used as the testset. We also selected 1–40 top-ranked genes for each class for
classiﬁcation, respectively. Fig. 4 shows the distribution of er-
ror rate. For training set 20 genes gave the zero error rate.
The test set showed the minimum error (2.94%) when 11–25
genes for each class used and the number of misclassiﬁcation
is one. The test error rates reached to 5.8% using 21 active
genes by PAM and a set of 16 genes obtained 2.94% test error
by ClaNC.
Fig. 4. Classiﬁcation error rate of Leukemia data.
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The third dataset on lymphoma classiﬁcation was originally
analyzed by Alizadeh et al. [17]. The dataset contains gene expres-
sion levels for 4026 genes from 58 lymphoma patients. The sam-
ples are classiﬁed into diffuse large B-cell lymphoma and
leukemia (DLCL), follicular lymphoma (FL) and chronic lympho-Fig. 5. The suitability score of eachcytic leukemia (CLL). We selected a random subset of 38 samples
as training set and the remaining 20 samples formed the test set.
Fig. 5 shows the suitability score of each gene in the lymphoma
data. Similar to SRBCT and leukemia data, only a small number of
genes are suitable for distinguishing the three classes. We also se-
lected 1–10 and 15 top-ranked genes for the three classes for clas-
siﬁcation, respectively (see Supplementary material). Table 1gene in the Lymphoma data.
Fig. 6. Classiﬁcation error rate of Lymphoma data.
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ﬁvefold cross-validation. The suitability score requires 6 genes to
drop the error rate bellow 5%. Using 12 active genes, the error rate
reach to 2%. The minimum error for PAM and ClaNC are 14% and
2%. However, the error rate is 0.14% using 30 genes by the suitabil-
ity score. The misclassiﬁcation error rate for suitability score is
lower than that for ClaNC and PAM. The 30 gene model provides
the sensitivity 99.89%, 1, and 1 for DLCL, FL, and CLL, respectively.
Using the 30 active genes could predict outcome with a speciﬁcity
of 1, 99.91%, and 1 for DLCL, FL, and CLL, respectively. To predict
new samples, 38 samples were used as the training set for selecting
genes and developing classiﬁcation models, while the remaining
20 samples were used as the test set. We also selected 1–40 top-
ranked genes for each class for classiﬁcation, respectively. Fig. 6
shows the distribution of error rate. As shown in Fig. 6, the training
and test set showed the zero error rate when 3–40 genes for each
class used, indicting our method is steady in handling classiﬁcation
tasks. The development of suitability score for gene selection im-
proved the performance of nearest centroid classiﬁcation, as the
classiﬁcation error for training and test set are decreased with
the introduction of suitability score for gene selection. Gene selec-
tion by suitability score and the nearest centroid classiﬁer are all
based on class centroid, the principle of them are identical, so
the classiﬁcation result is satisﬁed. It can be seen that our method
are useful in handling classiﬁcation tasks and is steady in handling
classiﬁcation tasks
4. Conclusion
The selection of genes is a key step in developing a successful
gene expression-based data analysis system. In this paper, the suit-
ability score was developed for genes selection and combined with
nearest centroid classiﬁcation for tumor classiﬁcation. Three differ-
ent microarray data sets which represent binary and multiple clas-
siﬁcation, respectively, were used by the proposed suitability score
method and show satisfactory performance. The results havedemonstrated that the proposed method is a useful tool for gene
selection and mining high dimension data.
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